Literature DB >> 2976084

Photodynamic therapy is potentiated by Co60 and intratumoral injection of hematoporphyrin derivative.

H Kostron1, M R Swartz, R L Martuza.   

Abstract

Hematoporphyrin derivative injected directly into a subcutaneous rat glioma resulted in a significant greater tumor growth inhibition than hematoporphyrin derivative injected parenterally upon stimulation by light, Co60 or by combination of the above. The photodynamic effect was analyzed in an in vivo and in an in vitro clonogenic assay. The directly injected hematoporphyrin derivative without external activation inhibited tumor growth to 34%. Light and directly injected HPD inhibited tumor growth to 3%, whereas 4, 8 and 16 Gy of Co60 produced a growth inhibition to 11%, 0.05% and 0.00% respectively. This cytotoxic effect of the ionizing radiation is further potentiated by the addition of light, resulting in a growth inhibition to 0.1%, 0.00% and 0.00% respectively for the three corresponding radiation doses. The direct intratumoral injection of HPD minimizes the side effects and increases the effect of the photodynamic therapy as compared to the parenterally administered HPD. This direct injection modality could be of potential value in the treatment of human gliomas or other tumors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2976084     DOI: 10.1007/bf02327395

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  16 in total

1.  Photodynamic therapy of malignant brain tumors: clinical and neuropathological results.

Authors:  H Kostron; G Weiser; E Fritsch; V Grunert
Journal:  Photochem Photobiol       Date:  1987-11       Impact factor: 3.421

Review 2.  Porphyrin photosensitization and phototherapy.

Authors:  J Moan
Journal:  Photochem Photobiol       Date:  1986-06       Impact factor: 3.421

Review 3.  Hematoporphyrin and HPD: photophysics, photochemistry and phototherapy.

Authors:  D Kessel
Journal:  Photochem Photobiol       Date:  1984-06       Impact factor: 3.421

4.  Interaction of hyperthermia and photoradiation therapy.

Authors:  S M Waldow; T J Dougherty
Journal:  Radiat Res       Date:  1984-02       Impact factor: 2.841

5.  Quantitation of hematoporphyrin derivative in human gliomas, experimental central nervous system tumors, and normal tissues.

Authors:  R E Wharen; R E Anderson; E R Laws
Journal:  Neurosurgery       Date:  1983-04       Impact factor: 4.654

6.  Comparison of mutagenicity and induction of sister chromatid exchange in Chinese hamster cells exposed to hematoporphyrin derivative photoradiation, ionizing radiation, or ultraviolet radiation.

Authors:  C J Gomer; N Rucker; A Banerjee; W F Benedict
Journal:  Cancer Res       Date:  1983-06       Impact factor: 12.701

7.  Photoradiation therapy in the treatment of malignant brain tumors: a phase I (feasibility) study.

Authors:  E R Laws; D A Cortese; J H Kinsey; R T Eagan; R E Anderson
Journal:  Neurosurgery       Date:  1981-12       Impact factor: 4.654

8.  Type I and type II mechanisms in the photosensitized lysis of phosphatidylcholine liposomes by hematoporphyrin.

Authors:  L I Grossweiner; A S Patel; J B Grossweiner
Journal:  Photochem Photobiol       Date:  1982-08       Impact factor: 3.421

9.  Distribution, retention, and phototoxicity of hematoporphyrin derivative in a rat glioma. Intraneoplastic versus intraperitoneal injection.

Authors:  H Kostron; D A Bellnier; C W Lin; M R Swartz; R L Martuza
Journal:  J Neurosurg       Date:  1986-05       Impact factor: 5.115

10.  Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy.

Authors:  B W Henderson; S M Waldow; T S Mang; W R Potter; P B Malone; T J Dougherty
Journal:  Cancer Res       Date:  1985-02       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.